Skip to main content
. 2016 Feb 1;6(2):155–164. doi: 10.1002/2211-5463.12032

Table 1.

Clinical association analyses of miR‐497 expression in HCC

Clinicopathologic features n = 86 miR‐497 expression P
Low High
Age (year)
<50 25 14 11 0.476
≥50 61 29 32
Sex
Male 68 35 33 0.596
Female 18 8 10
HBV
Absent 24 10 14 0.336
Present 62 33 29
Serum AFP level (ng·mL−1)
<20 20 6 19 0.002*
≥20 66 37 24
Tumor size (cm)
<5 27 8 19 0.011*
≥5 59 35 24
No. of tumor nodules
1 60 29 31 0.639
≥2 26 14 12
Cirrhosis
Absent 31 13 18 0.261
Present 55 30 25
Venous infiltration
Absent 46 19 27 0.084
Present 40 24 16
Edmondson–Steiner grading
I + II 51 20 31 0.016*
III + IV 35 23 12
TNM tumor stage
I + II 67 28 39 0.004*
III + IV 19 15 4

HCC, hepatocellular carcinoma; HBV, hepatitis B virus; AFP, alpha‐fetoprotein; TNM, tumor–node–metastasis.

*Statistically significant.